Trial intelligence / Profile preview

Oral zinc sulfate for reduction of jaundice in term neonates

IRCT201306031162N19Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
May 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of zinc in jaundice and hyperbilirubinemia, sponsored by Mashhad University of Medical Sciences. Started May 2013; status: completed.

02

Drugs

zinc
03

Conditions

jaundicehyperbilirubinemia

Beyond the preview

Go deeper on IRCT201306031162N19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201306031162N19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call